Decreased severity of Shiga toxin-producingEscherichia colihaemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease

التفاصيل البيبلوغرافية
العنوان: Decreased severity of Shiga toxin-producingEscherichia colihaemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease
المؤلفون: Michael L. Moritz, Matthew Geramita, Johannes Hofer, James D. Cooper
المصدر: BMJ Case Reports. :bcr-2017
بيانات النشر: BMJ, 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, congenital, hereditary, and neonatal diseases and abnormalities, von Willebrand Disease, Type 1, Article, 03 medical and health sciences, chemistry.chemical_compound, Von Willebrand factor, hemic and lymphatic diseases, Escherichia, Lactate dehydrogenase, medicine, Von Willebrand disease, Humans, Platelet, Child, Escherichia coli Infections, Creatinine, Shiga-Toxigenic Escherichia coli, biology, business.industry, Acute kidney injury, General Medicine, medicine.disease, biology.organism_classification, Complement system, 030104 developmental biology, chemistry, Hemolytic-Uremic Syndrome, Immunology, cardiovascular system, biology.protein, Female, business, circulatory and respiratory physiology
الوصف: Shiga toxin-producing Escherichia coli-associated haemolytic uraemic syndrome (STEC-HUS) is characterised by haemolytic anaemia, thrombocytopenia and acute kidney injury. Von Willebrand Factor (vWF) is an important mediator of normal thrombi formation and indirect evidence suggests that vWF may play an important role in Shiga toxin-induced thrombi formation. Clinical evidence supporting the role of vWF in STEC-HUS is lacking. A 10-year-old girl with type 1 von Willebrand Disease (vWD) had a mild case of STEC-HUS, with nadir haemoglobin 7.3 g/dL and platelet count 105×10(9) cells/L and peak serum creatinine 0.56 mg/L and lactate dehydrogenase 741 U/L. This is the first report of STEC-HUS in a patient with vWD. We speculate that the quantitative deficiency of vWF associated with type 1 vWD may have attenuated the course of disease by reducing platelet aggregation, complement activation and thrombi formation. This case adds to a growing literature supporting a link between vWF and STEC-HUS.
تدمد: 1757-790X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::203808b7da764790902b5a401dd4f630Test
https://doi.org/10.1136/bcr-2017-221043Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....203808b7da764790902b5a401dd4f630
قاعدة البيانات: OpenAIRE